Signalling pathways involved in antiproliferative effects of IGFBP-3: a review.
about
Preadministration of High-Dose Salicylates, Suppressors of NF- B Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation TherapyCross-species global and subset gene expression profiling identifies genes involved in prostate cancer response to seleniumAssociation between insulin-like growth factor-binding protein-3 polymorphism-202 A/C and the risk of prostate cancer: a meta-analysisEGF-mediated regulation of IGFBP-3 determines esophageal epithelial cellular response to IGF-IIdentification of differentially expressed genes induced by angiotensin II in rat cardiac fibroblastsTranscriptional profiling of ErbB signalling in mammary luminal epithelial cells--interplay of ErbB and IGF1 signalling through IGFBP3 regulation.Insulin-like growth factor-binding protein-5 stimulates growth of human intestinal muscle cells by activation of G{alpha}i3.Integrated multidimensional analysis is required for accurate prognostic biomarkers in colorectal cancer.A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among CaucasiansNovel treatments for cancer cachexia.Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3IGFBP-3, a marker of cellular senescence, is overexpressed in human papillomavirus-immortalized cervical cells and enhances IGF-1-induced mitogenesisIGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms.Dual inhibition of epidermal growth factor receptor and insulin-like growth factor receptor I: reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma.Effects of quercetin on insulin-like growth factors (IGFs) and their binding protein-3 (IGFBP-3) secretion and induction of apoptosis in human prostate cancer cells.Various components of the insulin-like growth factor system in tumor tissue, cerebrospinal fluid and peripheral blood of pediatric medulloblastoma and ependymoma patients.Novel protective properties of IGFBP-3 result in enhanced pericyte ensheathment, reduced microglial activation, increased microglial apoptosis, and neuronal protection after ischemic retinal injury.IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer.Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development.TNFα inhibits IGFBP-3 through activation of p38α and casein kinase 2 in human retinal endothelial cellsRole of traditional and new biomarkers in breast carcinogenesis.Gene Expression Profiling Identifies Interferon Signalling Molecules and IGFBP3 in Human Degenerative Annulus FibrosusProtein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude miceHistone deacetylase inhibitors enhance the apoptotic activity of insulin-like growth factor binding protein-3 by blocking PKC-induced IGFBP-3 degradationEffect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft modelAnalysis of circulating insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) in tobacco smokers and non-smokers.Expression of angiogenic growth factors in laryngeal carcinoma.Possible roles of insulin, IGF-1 and IGFBPs in initiation and progression of colorectal cancer.Insulin-like growth factor binding proteins-3 and -5: central mediators of fibrosis and promising new therapeutic targets.Targeted therapy in nonmelanoma skin cancers.Suppression of IGF binding protein-3 by palmitate promotes hepatic inflammatory responses.IGFBP-3 can either inhibit or enhance EGF-mediated growth of breast epithelial cells dependent upon the presence of fibronectin.Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient miceDistinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines.Expression of insulin-like growth factor-binding protein 5 in neuroblastoma cells is regulated at the transcriptional level by c-Myb and B-Myb via direct and indirect mechanisms.Modulation of the IGF system and proliferation in human endometrial stromal cells by metformin: a dose-dependent effect.IGFBP-3 activates TGF-beta receptors and directly inhibits growth in human intestinal smooth muscle cells.Overexpression of Aurora-A in primary cells interferes with S-phase entry by diminishing Cyclin D1 dependent activities.Comparison of replicative senescence and stress-induced premature senescence combining differential display and low-density DNA arrays.Analysis of circulating insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) in tobacco smokers and non-smokers.
P2860
Q22299231-8CEC6826-2DCA-4CE3-A8A9-9253B1B9D22CQ24805093-85E3E544-1D9B-4F06-965E-D6D621BDCC96Q28077769-C4B6DD4E-49FF-4D58-A796-35D0CF8CBD71Q28275900-E394219F-3A3F-4F62-9307-1E040BCB9E9EQ28294488-8F3501C6-82D4-4120-AC96-AF30BF8EB870Q33692428-6218A314-F92F-4448-8A1E-CA4DCDCB2196Q33771765-3606B52E-988C-4265-ABFC-D354F100C804Q33838394-42C419F9-86E5-4D1A-BAE1-71C28662EDF8Q33980349-9A9564DC-28E2-4C2F-9E2B-84C55782D01DQ34005616-11E324AD-7CB3-469B-AEA3-58E11D89A841Q34073234-88DD8B76-5638-47BD-9378-FF49A2A03F81Q34151999-4D4CEE38-7BA8-48B9-8514-7484345C03D5Q34356588-A5C5BBF8-484C-4AE5-BB9B-9E27EDC82F4FQ34442002-655953E3-89FA-454D-9725-3B2629AA056DQ34695649-3238ADC1-1B42-40CA-8D93-AD7E397159BCQ34778529-A5100E35-8694-4849-9560-C0EAFFDF4C4FQ34805398-82652E7E-4712-47A2-BF1E-03AD3CC68901Q34958659-B58D1F86-CB5D-412B-9876-D368F3F49ADCQ35001398-539EF048-4539-441A-BD0D-179F825D85BFQ35215117-4EB8A153-1AE2-4536-A8EE-EA67A7436085Q35572905-0BBBAD64-39D7-418F-A2AC-B3F95F712159Q36188811-5AE94773-854E-4042-9662-5505D22A24E1Q36289925-3535BA1C-41B9-4CEE-BF64-18E9B55DD0B6Q36767863-EEAC0B03-E491-43A8-9C28-98B0281ECD3DQ37057597-9C4ACC02-5ECA-4933-9177-FE52C0A7E746Q37165281-2D38CFD9-8ABB-4F52-8012-B0F407565F48Q37560826-EDE178C3-59C1-46D2-9340-7362173FDE43Q37587287-C63BA4AB-BAAE-446D-88DA-3D15B301208EQ38026844-04F2D113-DBC4-4182-BD51-C98974EB3F83Q38161358-3280CA76-F85B-4335-AA47-F8D3CA4ECEC5Q39461923-58E4F611-AA8A-4899-BFE0-B9DDDA03A876Q39654146-32704D81-C5A6-4B29-A511-850CD9AEEE41Q39740877-9A0551CA-0E1E-42DB-952A-B14E924757C8Q40679032-EC68D121-B369-4C5E-A0B9-0C35F60FEC07Q40735954-8A5FFE7F-FC88-4A6A-A5A3-E4C5478ED809Q41425232-87E3E147-5F49-4A13-85FC-4A89A8D0B18EQ42462619-54ECF5F3-9275-49C9-BC0B-B1D39F906A60Q42708398-4D3AA25F-73BC-478B-BDDC-AA61EBC54486Q46553815-31EFA714-48ED-4766-B4FE-73A86E94F49EQ46661769-E0A33BD0-69DA-4286-B61B-26D92FFB0DA3
P2860
Signalling pathways involved in antiproliferative effects of IGFBP-3: a review.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Signalling pathways involved in antiproliferative effects of IGFBP-3: a review.
@ast
Signalling pathways involved in antiproliferative effects of IGFBP-3: a review.
@en
Signalling pathways involved in antiproliferative effects of IGFBP-3: a review.
@nl
type
label
Signalling pathways involved in antiproliferative effects of IGFBP-3: a review.
@ast
Signalling pathways involved in antiproliferative effects of IGFBP-3: a review.
@en
Signalling pathways involved in antiproliferative effects of IGFBP-3: a review.
@nl
prefLabel
Signalling pathways involved in antiproliferative effects of IGFBP-3: a review.
@ast
Signalling pathways involved in antiproliferative effects of IGFBP-3: a review.
@en
Signalling pathways involved in antiproliferative effects of IGFBP-3: a review.
@nl
P2860
P356
P1476
Signalling pathways involved in antiproliferative effects of IGFBP-3: a review.
@en
P2093
R C Baxter
P2860
P304
P356
10.1136/MP.54.3.145
P407
P577
2001-06-01T00:00:00Z